• Molecular NameSodium Tetradecyl Sulfate
  • SynonymMonotetradecylsulfate sodium salt; (S; T; D; ); Sodium myristyl sulfate; STD; Tetradecyl hydrogen sulphate; Tetradecyl sodium sulfate; Tetradecyl sulfate; Tetradecyl sulfuric Acid
  • Weight294.456
  • Drugbank_IDDB00464
  • ACS_NON/A
  • Show 2D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)3.22
  • pkaN/A
  • LogD (pH=7, predicted)-0.88
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-1.53
  • LogSw (predicted, AB/LogsW2.0)0.0
  • Sw (mg/ml) (predicted, ACD/Labs)8.72
  • No.of HBond Donors1
  • No.of HBond Acceptors4
  • No.of Rotatable Bonds14
  • TPSA71.98
  • StatusFDA approved
  • AdministrationIntravenous injection
  • PharmacologyA sclerosant drug. It is commonly used in the treatment of varicose and spider veins of the leg, during the procedure of sclerotherapy.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)LD50=1250 mg/kg; LD50=3 ml/kg (Skin)
  • LD50 (mouse)N/A